AllianceBernstein’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

AllianceBernstein’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-60,000	Closed	-$1.57M	–	3256
2019 Q1	$1.57M	Buy	+60,000	New	+$1.12M	﹤0.01%	2033

AllianceBernstein's CMTA Position: Q2 2019 in Review

AllianceBernstein sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 60,000 shares — an estimated $1.57M sold.

AllianceBernstein first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $1.57M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

AllianceBernstein reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
AllianceBernstein sold 60,000 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $1.57M.
AllianceBernstein first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
AllianceBernstein's Clementia Pharmaceuticals Inc. position peaked at $1.57M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.